Drugs / Transduced CD34+ Cells
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00001399 | Dec 1993 → Feb 2009 | Fanconi anemia, pancytopenia | National Heart, Lung, and Blood Institute (NHLBI) | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Transduced CD34+ Cells | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00001399 ↗ |
| Modality | Cell therapy | “hematopoietic progenitors transduced with the normal FACC gene can be re-infused safely into FA(C) patients” NCT00001399 ↗ |
| Target | FACC | “with the FACC retroviral vector” NCT00001399 ↗ |